Is Verrica Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Verrica Pharmaceuticals Inc (VRCA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Verrica Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Verrica Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Verrica Pharmaceuticals Inc?

Muslim investors may consider investing in Verrica Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Verrica Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Verrica Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Verrica Pharmaceuticals Inc updated?

The Shariah compliance status of Verrica Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Verrica Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Verrica Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Verrica Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VRCA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 12, 2026

Report Source: 2025 Annual Report

Verrica Pharmaceuticals Inc. Stock Analysis VRCA

United States Health Care Micro Cap Report: 2025 Annual

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. The company is headquartered in West Chester, Pennsylvania and currently employs 76 full-time employees. The company went IPO on 2018-06-15. The firm's product portfolio consists of one approved product with several potential follow-on indications, as well as an additional pipeline product. Its commercial product, YCANTH (VP-102), is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. YCANTH (VP-102) is being developed for the treatment of molluscum contagiosum in adult and pediatric patients two years of age and older. The company is also engaged in developing YCANTH (VP-102) for a potential follow-on indication for the treatment of common warts. Its second development candidate, VP-315, is an oncolytic peptide-based injectable therapy for the potential treatment of dermatology oncologic conditions, including basal cell carcinoma (BCC).

Key Statistics of Verrica Pharmaceuticals Inc (VRCA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$6.21$6.90

Today's Open

$6.85

Volume

81.59K

P/E Ratio (TTM)

52 Week Range

$3.28$9.82

Market Cap

123.00M

Avg. Volume

94.54K

Dividend Yield

Financial Metrics & Statements of Verrica Pharmaceuticals Inc (VRCA)

FAQ's for Verrica Pharmaceuticals Inc (VRCA)

According to Musaffa’s Shariah screening methodology, Verrica Pharmaceuticals Inc (VRCA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.